Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bazuka is a prominent brand of over-the-counter (OTC) topical treatments developed and marketed by Diomed for the removal of warts, verrucas, corns, and calluses. The product range primarily features medicinal gels, such as Bazuka Gel and Bazuka Extra Strength Gel, which utilize high concentrations of salicylic acid, often in combination with lactic acid. These active ingredients function as keratolytics, breaking down the protein structure (keratin) of the skin lesion and the "intercellular cement" holding the skin cells together. This process softens the affected area, allowing for the gradual mechanical removal of the viral-infected tissue. Additionally, the brand includes Bazuka Sub-zero, a cryotherapy-based device that uses an aerosol spray to freeze the lesion. Bazuka is a well-established retail brand in the United Kingdom, known for its "once-daily" application regimen and its ability to form a protective, water-resistant film over the treated area.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Bazuka.